Search research articles
Contact Us
Filters
Showing results (751-760 of 903) with videos related to
Page
of 91
Sort By:
Leukemia
|
November 16, 2016
Mutations in the CCND1 and CCND2 genes are frequent events in adult patients with t(8;21)(q22;q22) acute myeloid leukemia
A-K Eisfeld, J Kohlschmidt, S Schwind, et al.
Blood
|
July 13, 2012
Genome-wide methylation profiling in decitabine-treated patients with acute myeloid leukemia
Pearlly Yan, David Frankhouser, Mark Murphy, et al.
Journal of Hematology & Oncology
|
June 24, 2021
A precision medicine classification for treatment of acute myeloid leukemia in older patients
Alice S Mims, Jessica Kohlschmidt, Uma Borate, et al.
Leukemia
|
June 21, 2014
Tumor antigen ROR1 targeted drug delivery mediated selective leukemic but not normal B-cell cytotoxicity in chronic lymphocytic leukemia
R Mani, Y Mao, F W Frissora, et al.
Blood
|
February 13, 2009
MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1
Ramiro Garzon, Shujun Liu, Muller Fabbri, et al.
Haematologica
|
October 15, 2020
Hodgkin lymphoma arising in patients with chronic lymphocytic leukemia: outcomes from a large multi-center collaboration
Deborah M Stephens, Ken Boucher, Elizabeth Kander, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 9, 2012
Quantitative DNA methylation analysis identifies a single CpG dinucleotide important for ZAP-70 expression and predictive of prognosis in chronic lymphocytic leukemia
Rainer Claus, David M Lucas, Stephan Stilgenbauer, et al.
Leukemia
|
January 25, 2017
Leukemia-cell proliferation and disease progression in patients with early stage chronic lymphocytic leukemia
E J Murphy, D S Neuberg, L Z Rassenti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 16, 2020
Phase II Study of Combination Obinutuzumab, Ibrutinib, and Venetoclax in Treatment-Naïve and Relapsed or Refractory Chronic Lymphocytic Leukemia
Kerry A Rogers, Ying Huang, Amy S Ruppert, et al.
Leukemia
|
February 24, 2023
Outcome prediction by the 2022 European LeukemiaNet genetic-risk classification for adults with acute myeloid leukemia: an Alliance study
Krzysztof Mrózek, Jessica Kohlschmidt, James S Blachly, et al.
Page
of 91
Search research articles
Search
Showing results (751-760 of 903) with videos related to
Sort By:
Page
of 91
Leukemia
|
November 16, 2016
Mutations in the CCND1 and CCND2 genes are frequent events in adult patients with t(8;21)(q22;q22) acute myeloid leukemia
A-K Eisfeld, J Kohlschmidt, S Schwind, et al.
Blood
|
July 13, 2012
Genome-wide methylation profiling in decitabine-treated patients with acute myeloid leukemia
Pearlly Yan, David Frankhouser, Mark Murphy, et al.
Journal of Hematology & Oncology
|
June 24, 2021
A precision medicine classification for treatment of acute myeloid leukemia in older patients
Alice S Mims, Jessica Kohlschmidt, Uma Borate, et al.
Leukemia
|
June 21, 2014
Tumor antigen ROR1 targeted drug delivery mediated selective leukemic but not normal B-cell cytotoxicity in chronic lymphocytic leukemia
R Mani, Y Mao, F W Frissora, et al.
Blood
|
February 13, 2009
MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1
Ramiro Garzon, Shujun Liu, Muller Fabbri, et al.
Haematologica
|
October 15, 2020
Hodgkin lymphoma arising in patients with chronic lymphocytic leukemia: outcomes from a large multi-center collaboration
Deborah M Stephens, Ken Boucher, Elizabeth Kander, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 9, 2012
Quantitative DNA methylation analysis identifies a single CpG dinucleotide important for ZAP-70 expression and predictive of prognosis in chronic lymphocytic leukemia
Rainer Claus, David M Lucas, Stephan Stilgenbauer, et al.
Leukemia
|
January 25, 2017
Leukemia-cell proliferation and disease progression in patients with early stage chronic lymphocytic leukemia
E J Murphy, D S Neuberg, L Z Rassenti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 16, 2020
Phase II Study of Combination Obinutuzumab, Ibrutinib, and Venetoclax in Treatment-Naïve and Relapsed or Refractory Chronic Lymphocytic Leukemia
Kerry A Rogers, Ying Huang, Amy S Ruppert, et al.
Leukemia
|
February 24, 2023
Outcome prediction by the 2022 European LeukemiaNet genetic-risk classification for adults with acute myeloid leukemia: an Alliance study
Krzysztof Mrózek, Jessica Kohlschmidt, James S Blachly, et al.
Page
of 91